Intus Bio
Paul Denslow is currently the Board Chair, CEO & Co-Founder, and Board Member at Intus Bio. He is also the Founder of Canford Partners, where he is involved in investing, syndication, consultancy, and fundraising across bio-tech and technology. Additionally, Paul serves as an Advisor for Modulo Bio, CytoVeris, and Quidient. He is also the President of Williams Land Corporation. With a background in finance, Paul has previously worked at companies like Standard Chartered Bank and HSBC in various senior roles. He holds a Bachelor of Science degree in Economics from the University of Bath.
This person is not in any teams
Intus Bio
Intus Bio is using its proprietary high-resolution, high-throughput assay and analysis technology to identify bacteria and deliver answers about the microbiome, with unprecedented detail, accuracy and scale. The company is powering groundbreaking research, discovery and services with clients and partners across the global pharmaceutical, diagnostic, and testing industries; is active in health, agricultural, and environmental fields; and continues to develop new and innovative partnerships, technologies, and applications.